Skip to main content

U.S. COVID Hospitalizations Rise for Fourth Straight Week

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

WEDNESDAY, Aug. 16, 2023 -- New hospitalizations for Americans with severe COVID are climbing once again.

The number of patients being admitted to hospitals has grown for each of the past four weeks, U.S. Centers for Disease Control and Prevention data shows. Southeastern states have been hit the hardest.

In the week ending Aug. 5, the United States had 10,320 newly hospitalized patients. That’s a 14.3% increase, but it's still much lower than last summer’s peak of more than 42,800 in a week.

The Southeastern region that includes Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina and Tennessee had nearly 4.6 new patients hospitalized with COVID-19 per 100,000 residents. Overall, the country saw just over 3 new patients per 100,000 residents.

Cases occurring at nursing homes were also high.

Severe COVID recently seems to have been striking seniors ages 75 and up most often. But according to nationwide emergency room data, children up to the age of 11 have also been frequently seen in the ER and have now tied with seniors.

In the region that includes Arkansas, Louisiana, New Mexico, Oklahoma and Texas, children’s visits to the ER are exceeding that of adults, at least for those ages 0 to 11, CBS News reported.

The variant EG.5 is now the dominant variant in the country, comprising 17.3% of U.S. infections.

Fall’s expected booster shots will target the XBB variant, but will also likely provide some protection against EG.5, which is a descendant of the XBB variant.

Still, the World Health Organization has warned that EG.5 could soon outcompete other XBB variants.

"EG.5 may cause a rise in case incidence and become dominant in some countries or even globally," the WHO said in a recent report on the variant.

Sources

  • CBS News

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Further Support and Information on COVID-19

Read this next

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

FRIDAY, June 7, 2024 -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for...

FDA Panel OKs New COVID Vaccine for Fall

THURSDAY, June 6, 2024 -- A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will...

Long COVID's Toll Outlined in New Report

THURSDAY, June 6, 2024 -- Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.